RealTimeDesign™

Realtime Design

Still haven’t found the time to try our powerful, web-based assay design software? Design & order using RTD and receive 50% off your first order.

Already loving the benefits of RTD? Receive a 15% discount off of all future orders designed and placed with RTD for a limited time. Take advantage of this offer while it lasts.

Learn More about our RTD offers.

Do You Have the Freedom to Operate?

Biosearch Legitimizes Your SNP Genotyping


Just recently, GTG granted Biosearch a license to their non-coding DNA patents. Biosearch is the first oligonucleotide synthesis company enabled to sell and manufacture oligos, probes and primers world-wide for genotyping within non-coding regions of any genome. You are free to conduct your SNP genotyping research using Biosearch oligos to power your method.

You can find our new SNP Genotyping Ad, “Do You Have the Freedom to Operate” published in the following:

  • Genome Technology's November Real-Time PCR Tech Guide
  • Bristol Meyer's Squibb 2007 Buyer's Guide
  • BioTechniques December Issue
  • Biosearch's website
As your first licensed oligonucleotide synthesis company, Biosearch has your bases covered!

For more information about our license, visit: www.FreedomtoSNP.com

All New BHQplus™ Probe

Fortified Probes Achieve Powerful Discrimination

Realtime Design

Biosearch now offers the BHQplus™ Probe! A product of Biosearch’s innovation, this new, advanced probe is characterized by:

  • Shorter length
  • Increased binding stability
  • Enhanced sequence specificity
  • Robust detection of AT-rich regions
  • Ideal for SNP discrimination
For more product details, please view our poster Genotyping with BHQplus™.
 

Unsubscribe: unsubscribe@biosearchtech.com

RealTimeDesign is a trademark of Biosearch Technologies, Inc. Biosearch's RealTimeDesign software is powered by ProbeITy by Celadon Laboratories, Inc; BHQplus, BHQ, Black Hole Quencher, CAL Fluor, Quasar and Pulsar are registered trademarks of Biosearch Technologies; Patents covering PCR are owned by Roche Molecular Systems, Inc. Certain methods of genotyping may be covered by separate patent restrictions. GTG holds patents to non-coding DNA. Offers mentioned in this newsletter is valid for a limited time only.